expr:content='data:blog.isMobile ? "width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0" : "width=1100"' name='viewport'/> variednewsandviews.blogspot.com: PerkinElmer Unveils Sophisticated in Vivo Imaging Facility at IISER ,Pune

Friday 22 November 2019

PerkinElmer Unveils Sophisticated in Vivo Imaging Facility at IISER ,Pune

Pune, Maharashtra, India


PerkinElmer, Inc., a worldwide pioneer dedicated to innovating for a healthier world, has revealed PerkinElmer India’s unveiling of an Advanced In Vivo Imaging Facility at the Indian Institute of Science Education and Research (IISER) Pune. Boasting of novel testing and analysis solutions, the laboratory will assist  in enlightening the present and future scientists of the region on progressive small animal imaging expertise which can aid propel findings in oncology, toxicology, infectious disease and more. This unique facility, which will also host an India-wide event yearly, joins the established PerkinElmer Centre of Excellence at IISER Pune which encompasses content analysis and automated liquid handling workstations, multispectral imaging and DNA/RNA analysis expertise.

The novel In Vivo facility will comprise PerkinElmer’s:
  • QuantumTM GX2 microCT imaging system for longitudinal studies, used with AccuCT™ software to conduct bone, pulomary and soft tissue analysis. 
  • IVIS® SpectrumTM in vivo imaging system, for high throughput with full tomographic optical imaging, plus Imaging Wizard oftware for 3D data analysis, visualization and reporting. 
  • VICTOR® NIVO™ multimode microplate reader.

As stated by Jayashree Thacker, President India, South Asia and Emerging Markets, PerkinElmer, “In Vivo imaging plays a profound role in advancing molecular and physiological research across disease models. Our latest collaboration with IISER Pune helps expose more researchers to it and is another step in supporting the scientific goals of the Skill India campaign.” She added, “This latest effort also continues to expand PerkinElmer’s presence as a strong innovator in India and to further grow our important relationships with leading in-country research organizations.”

Addressing the guests at the facility’s inaugural event, Prof. Jayant B. Udgaonkar, Director, IISER Pune observed, “This newest facility further enhances the institute’s efforts towards strengthening academic-industry collaborations. This in vivo imaging facility is a great addition to our ongoing partnership with PerkinElmer and will aid in expanding the scope of our research focus to physiological relevance.”
About PerkinElmer and PerkinElmer in India

With an objective aimed at innovating for a healthier world, PerkinElmer allows scientists, researchers and clinicians to cope up with their most crucial problems in science and health by offering exclusive instrument, informatics and service solutions for sophisticated testing and analysis. Since 1981, PerkinElmer has worked with clients in India, covering a broad array of markets consisting of pharmaceutical, food, life science, diagnostics and applied markets. PerkinElmer started direct operations in India in 2004 and presently has over 10,000 clients and over 550 employees in India. Worldwide, its devoted squad consists of 13,000 workers across 180 nations. Further facts are obtainable at www.perkinelmer.com.

About IISER Pune

The Indian Institute of Science Education and Research (IISER) Pune is a teaching and research institute founded in 2006 by the MHRD, Govt of India with the fundamental objective of integrating high quality research with undergraduate teaching to enhance science education in India and to improve the number and quality of future researchers of the nation. The institute offers a 5-year BS-MS dual degree programme, Integrated-PhD programmes for bachelor level students, and PhD programmes for Master's level students in several branches of science and mathematics. Positioned 23 in the 2019 National Institutional Ranking Framework, IISER Pune is among the key research and teaching organisations in India. 
 By ANJISHNU BISWAS 

No comments:

Post a Comment